🇺🇸 FDA
Patent

US 6498181

Synergistic tumorcidal response induced by histamine

expired A61KA61K31/417A61K39/395

Quick answer

US patent 6498181 (Synergistic tumorcidal response induced by histamine) held by Maxim Pharmaceuticals, Inc. expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Maxim Pharmaceuticals, Inc.
Grant date
Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/417, A61K39/395, A61K41/0038, A61P